Sugi Predict

Sugi Predict / Compounds / SCHEMBL3551052

SCHEMBL3551052

SCHEMBL3551052

CCCc1cc(-c2n[nH]c3cc(OC)ccc23)ccc1Oc1cccc(C[C@@]2(C)OC(=O)NC2=O)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR2 P21802 1/20 0.36
▸ FGFR3 P22607 1/20 0.36
▸ AURKB Q96GD4 4/20 0.36
▸ JAK1 P23458 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ NR1H2 P55055 2/20 0.34
▸ NR1H3 Q13133 2/20 0.34
▸ PGR P06401 1/20 0.34
▸ PRKACA P17612 1/20 0.34
▸ PRKACG P22612 1/20 0.34
▸ PRKACB P22694 1/20 0.34
▸ ROCK2 O75116 2/20 0.33
▸ FGFR1 P11362 1/20 0.33
▸ PPARG P37231 3/20 0.33
▸ PLK4 O00444 2/20 0.33
▸ FLT3 P36888 2/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ GPR55 Q9Y2T6 1/20 0.33
▸ PPARD Q03181 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13134027 0.92 FGFR2 (0.37) FGFR2FGFR3AURKBNR1H2NR1H3
SCHEMBL13282969 0.91 FGFR1 (0.41) FGFR2FGFR3JAK1JAK3NR1H2
SCHEMBL3551384 0.91 MAP2K4 (0.36) FGFR2FGFR3NR1H2NR1H3FGFR1
SCHEMBL13114528 0.87 PPARG (0.42) NR1H2NR1H3PPARGCNR1CNR2
SCHEMBL13114534 0.87 PPARG (0.39) FGFR2FGFR3AURKBNR1H2NR1H3
SCHEMBL3553128 0.86 NR1H2 (0.36) NR1H2NR1H3PRKACAPRKACGPRKACB
SCHEMBL5175340 0.83 PPARG (0.46) NR1H2NR1H3PPARGPPARDPPARA
SCHEMBL14459759 0.83 PPARG (0.46) NR1H2NR1H3PPARGPPARDPPARA
SCHEMBL3543482 0.82 HPGD (0.41) CNR1CNR2GPR55
SCHEMBL13283071 0.80 NR1H2 (0.33) FGFR2FGFR3AURKBJAK1JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807692-B2 Antidiabetic oxazolidinediones and thiazolidinediones MERCK SHARP & DOHME CORP. (US) 2010-10-05 — — US disclosed
US-7807692-B2 Antidiabetic oxazolidinediones and thiazolidinediones MERCK SHARP & DOHME CORP. (US) 2010-10-05 — — US disclosed
US-7807692-B2 Antidiabetic oxazolidinediones and thiazolidinediones MERCK SHARP & DOHME CORP. (US) 2010-10-05 — — US disclosed
US-20100168164-A1 Antidiabetic Oxazolidinediones and Thiazolidinediones MERCK SHARP & DOHME CORP. 2010-07-01 — — US disclosed
US-20100168164-A1 Antidiabetic Oxazolidinediones and Thiazolidinediones MERCK SHARP & DOHME CORP. 2010-07-01 — — US disclosed
US-20100168164-A1 Antidiabetic Oxazolidinediones and Thiazolidinediones MERCK SHARP & DOHME CORP. 2010-07-01 — — US disclosed
WO-2007008501-A1 ANTIDIABETIC OXAZOLIDINEDIONES AND THIAZOLIDINEDIONES MERCK & CO., INC. (US) 2007-01-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168164-A1 Antidiabetic Oxazolidinediones and Thiazolidinediones PPARD, PPARA, PPARG FGFR2 300/4885FGFR3 1095/4885AURKB 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.